By Rachel Cohen, North America Director, DNDi
The new coronavirus variant, Omicron, has renewed uncertainty over the future of the pandemic. The variant seems to be spreading quickly, but the degree to which it can evade or blunt the protection of vaccines remains unknown. While getting vaccines to everyone who needs them remains a top priority, the world has never effectively fought an infectious disease with just one set of tools. The treatment options for Covid-19 will be greatly expanded by new oral antiviral pills. These drugs have the potential to lessen the impact of Covid-19 worldwide if the people who need them can get them.
